Crispr therapy heralds a new era in genetic medicine, with indications for sickle cell anaemia and beta thalassemia.
Customised, tailored, targeted: The new precision medicine promises high diagnostic and therapeutic accuracy
Researchers at Google DeepMind have used artificial intelligence to predict whether mutations in human genes are likely to be harmful.
